Named on one round in the feed.
Since ~ 2019-02-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
HiberCell A biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $60.8M | ~ 2019-02-07 | [ PART ] |